Relationship between polycystic ovary syndrome and platelet distribution width

2015 ◽  
Author(s):  
Ozgur Yilmaz ◽  
Muzaffer Temur ◽  
Mehmet Calan ◽  
Elif Pelin Ozun Ozbay ◽  
Murat Karakulak ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Platelet Distribution Width ◽  
Ovary Syndrome ◽  
Distribution Width

Association between red blood cell distribution width and polycystic ovary syndrome

2014 ◽  
Vol 40 (4) ◽  
pp. 181-187 ◽  
Author(s):  
Özgür Yilmaz ◽  
Calan Mehmet ◽  
Sefa Kelekci ◽  
Muzaffer Temur
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Polycystic Ovary ◽  
Cell Distribution ◽  
Ovary Syndrome ◽  
Distribution Width ◽  
Red Blood Cell Distribution

scholarly journals Peripheral hematological parameters in women with polycystic ovary syndrome

2020 ◽  
Vol 48 (9) ◽  
pp. 030006052095228
Author(s):  
Nadiah A ALhabardi ◽  
Osama Al-Wutayd ◽  
Khalid M Eltayieb ◽  
Yasir S Shiha ◽  
Ahmad I AL-Shafei ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Blood Cells ◽  
Polycystic Ovary ◽  
Hematological Parameters ◽  
White Blood Cells ◽  
Red Cell ◽  
Cell Distribution ◽  
Platelet Volume ◽  
Ovary Syndrome ◽  
Distribution Width

Objective There have been few studies on hematological parameters (e.g., hemoglobin, red cell distribution width, white blood cells, and mean platelet volume), and polycystic ovary syndrome (PCOS). This study aimed to compare hematological parameters between women with PCOS and controls. Methods We performed an age-matched case–control study in Faisal bin Mishal Center for Infertility, Buraidah (Kingdom of Saudi Arabia). The cases were women with PCOS and an equal number of healthy women were enrolled as controls. The basic gynecological history was recorded and blood samples were analyzed for blood parameters using an automated hematology analyzer. Results The two groups (60 women in each arm of the study) were similar in age. However, body mass index was significantly higher in women with PCOs compared with controls. There were no significant differences in any of the hematological parameters (hemoglobin, red blood cells, red cell distribution width, white blood cells, platelets, and mean platelet volume) between the two groups. Conclusion There does not appear to be a significant difference in hematological parameters in Saudi women with PCOS and healthy controls. A larger study on this issue is required in the future.

The role of vitamin D in metabolic and reproductive disturbances of polycystic ovary syndrome: A narrative mini-review

2020 ◽  
pp. 1-8
Author(s):  
Daniela Menichini ◽  
Gianpiero Forte ◽  
Beatrice Orrù ◽  
Giuseppe Gullo ◽  
Vittorio Unfer ◽  
...  
Keyword(s):  
Vitamin D ◽  
Polycystic Ovary Syndrome ◽  
Embryo Quality ◽  
Polycystic Ovary ◽  
Vitamin D Supplementation ◽  
Endometrial Receptivity ◽  
Metabolic Disturbances ◽  
Ovary Syndrome ◽  
Beneficial Role

Abstract. Vitamin D is a secosteroid hormone that plays a pivotal role in several metabolic and reproductive pathways in humans. Increasing evidence supports the role of vitamin D deficiency in metabolic disturbances and infertility in women with polycystic ovary syndrome (PCOS). Indeed, supplementation with vitamin D seems to have a beneficial role on insulin resistance and endometrial receptivity. On the other hand, exceedingly high levels of vitamin D appear to play a detrimental role on oocytes development and embryo quality. In the current review, we summarize the available evidence about the topic, aiming to suggest the best supplementation strategy in women with PCOS or, more generally, in those with metabolic disturbances and infertility. Based on the retrieved data, vitamin D seems to have a beneficial role on IR, insulin sensitivity and endometrial receptivity, but high levels and incorrect timing of administration seem to have a detrimental role on oocytes development and embryo quality. Therefore, we encourage a low dose supplementation (400–800 IU/day) particularly in vitamin D deficient women that present metabolic disturbances like PCOS. As far as the reproductive health, we advise vitamin D supplementation in selected populations, only during specific moments of the ovarian cycle, to support the luteal phase. However, ambiguities about dosage and timing of the supplementation still emerge from the clinical studies published to date and further studies are required.

Metformin Treatment Ameliorates Liver Injury Indicating Fatty Liver Polycystic Ovary Syndrome

2015 ◽  
Vol 53 (01) ◽  
Author(s):  
S Tan ◽  
N Vollmar ◽  
S Benson ◽  
LP Bechmann ◽  
G Gerken ◽  
...  
Keyword(s):  
Liver Injury ◽  
Polycystic Ovary Syndrome ◽  
Fatty Liver ◽  
Polycystic Ovary ◽  
Metformin Treatment ◽  
Ovary Syndrome
Sign in / Sign up

Export Citation Format

Share Document